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Abstract: Diabetes is a disease that affects millions of people in the United States, but also all
around the world. With different types of diabetes that exist, it has been hard for researchers to
find a cure for diabetes. Current diabetes treatments are expensive, and not always available for
1

patients around the world. Researchers have tried to understand how insulin, Islets of Langerhans
and diabetes functions in order to try to find more efficient treatments and possibly a cure in the
future. Islet -cells are found in the pancreas and produce the hormone insulin. In patients with
Type 1 diabetes, islet -cells don’t function correctly, leading to very little or no insulin being
produced. This is obviously an issue, if -cells don’t produce insulin, glucose cannot be. With
this knowledge, researchers have explored a way to possibly use transplanted -cell islets from
donor cadavers to help type 1 diabetic patients whom are typically insulin dependent, become
insulin independent. Islet transplantation has been explored in many countries. Being a new,
experimental procedure many doctors are skeptical about this new treatment. Some patients
seeing good results, gives hope that with future research and more trials performed that this can
be an effective treatment for diabetes. Although this new treatment seems exciting and ground
breaking for type 1 diabetic patients, it still hasn’t been found to work as well as insulin. There’s
a fair chance that with further research there will be treatments that work as effective or even
more than insulin, but for now, insulin dependent patients will have to continue to use insulin as
their main treatments.
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Introduction
Today, 336 million people around the world struggle with diabetes, while 4.1 million
people die from diabetes every year (Ashcroft, 2012). Diabetes is a disease in which the body has
a high level of blood glucose. Type 1 diabetes is when the body does not make insulin. This
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happens due to diminished functions of -cells in the pancreas, which leads to no production of
insulin. Type 2 diabetes is when the body does not make insulin correctly. Insulin is a protein
that lowers blood glucose in the body and is produced by -cells. Current treatments for diabetes
are very expensive and not many people around the world are able to afford these treatments.
According to (Ashcroft, 2012) the cost of diabetes in the United States per day is around $612M.
Improved and cost-effective treatments need to be developed to target how our body produces
insulin. Finding a way to improve treatments and lower costs could potentially save the lives of
many people with this disease. Since being insulin dependent can be very expensive, researchers
have tried to find a way to make these patients no longer need insulin to survive. Islet
transplantations need a lot more research, clinical trials and decrease in flaws overall to be more
accepted by doctors around the world. Future treatments might be more effective than current
treatments for diabetes, but it will take a lot more work to make this happen. This review will
analyze types of diabetes, traditional treatments, and describe new Islet -cell research to
develop improved treatments for diabetes. This review will also state whether current treatments
or newer treatments are more effective at managing diabetes type 1 and type 2.

What is insulin?
The most effective treatment for diabetes today is insulin. Insulin is a hormone that
lowers blood glucose and is produced by the pancreas. Insulin is used to control glucose after a
meal, this is done in several different ways. (Aronoff, 2004). Insulin sends signals to the cells in
the body to increase their consumption of glucose. Insulin also helps the liver stimulate
glycogenesis- which is the formation of glycogen from sugar. The body uses glucose as a form
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of energy. Insulin is a highly regulated process, where getting disrupted can cause serious issues.
Insulin was isolated and used for treatments by Frederick Banting and medical student Charles
Best. Together they experimented on dogs, soon after they began to experiment on humans.
These scientists experimented on a 14-year-old boy, his symptoms, which today would be called
diabetes, were diminished by their treatments. Banting alongside of professor McLeod won a
Noble Prize in 1923. (Wilcox, 2005) The structure of insulin is very complex, it consists of two
chains- A and B. (Wilcox, 2005) These two chains are linked together by disulfide bonds. (Fu,
2013) Chain A consists of 21 amino acids, and chain B consists of 30 amino acids. Together
Insulin consists of 51 amino acids, which was discovered in 1952. (Wilcox, 2005) Insulin
encodes and is synthesized as Preproinsulin. Preproinsulin is made up of a signal peptide, B
chain, C peptide and A chain. When the signal peptide gets removed this is then converted to
proinsulin. Proinsulin is then converted to insulin. Insulin alongside of C-peptide are stored in
granules- where they wait until they are needed. (Fu, 2013) Insulin is an important hormone and
when it is defective it can lead to Diabetes. The most common insulin related problem is
Diabetes.
Traditional Treatments for Type 1 and 2 Diabetes
Type 1 diabetes is when the body does not produce insulin, this type of diabetes is the
least common type of diabetes. (CDC) Type 1 diabetes is sometimes described as an
“autoimmune disease” because it causes the body to attack itself harming -cells that produce
insulin. This type of diabetes is not known to be caused by environmental factors, such as
lifestyle and diet. (CDC) Type 1 diabetes treatments are not the best, since the pancreas produces
little to no insulin. Treatments consist of managing blood sugar, and living a healthy life style
and insulin injections. Insulin is required for type 1 diabetic patients because without insulin,
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glucose cannot be moved into the cells to be used for energy. Insulin pumps are commonly used
for treatment and are being used more than daily multiple insulin injections (Atkinson, 2013). A
study showed that insulin pumps actually lower HbA1C concentrations more than daily multiple
insulin injections. (Atkinson, 2013) HbA1c is glycated hemoglobin, this is created when
hemoglobin joins with glucose making it glycated. (Diabetes.co.uk). There are several different
types of insulin. Rapid acting, regular, intermediate acting, long acting, and premix. Rapid acting
insulin starts working in 15 minutes, this is generally taken right before a meal. Regular insulin
starts working within 30 minutes, this is also taken right before a meal, but it lasts longer than
rapid acting insulin. Intermediate insulin lasts about 10-16 hours and is taken twice a day. Long
acting insulin lasts for about 20-24 hours, so it is taken once a day. Lastly, premixed insulin is
the combination of two or more types of insulin (Smith-Marsh). Glucose monitoring is also used
as a treatment for type 1 diabetes. This is pretty simple, patients with diabetes monitor their
glucose levels throughout the day. Patients then adjust their diet accordingly to the levels that
were read on the monitor. If levels were found higher than normal, patients will decrease their
consumption of carbohydrates and added sugars, and will increase insulin intake to help stabilize
glucose.

Type 2 diabetes is when the body doesn’t produce insulin in the right way. Type 2 diabetic
patients do produce the hormone insulin on their own, but it isn’t effective and produced
correctly. Since type 2 diabetic patients already produce insulin, they do not need insulin
injections like type 1 diabetic patients do. Although most type 2 diabetic patients are not insulin
dependent, some patients of type 2 diabetes can become insulin dependent later on in their
lifetime as their condition worseness. (add cite.) Type 2 diabetes is known to be caused by
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obesity. As said by author Olokoba, obesity contributes to about 55% of type 2 diabetes.
Genetics play a major role in the connection to type 2 diabetes. A study showed that if a family
member has diabetes, there is 25% connection between developing diabetes yourself. (Olokoba,
2012) Treatments for type 2 diabetes are not the best either. Treatments consist of healthy diet
and lifestyle. (Olokoba, 2012) Diet and exercise are important for managing type 2 diabetes,
since type 2 is linked to obesity, losing weight and eating healthy can help control type 2
diabetes. Although diabetes is not yet cured, type 2 diabetes can be prevented with a healthy diet
and lifestyle.

Cost of Diabetic Treatments
Managing diabetes 1 and 2 can be very expensive. Studies have shown that the cost of type 1
diabetes annually is around $14.4- $14.9 billion in the united states. (Atkinson, 2014) Since type
1 diabetic patients require insulin to survive, most are forced to pay the price for insulin,
regardless if insurance covers it or not. A single vial of insulin costs $100-$500 dollars according
to GoodRx, depending on brands. If you are an insulin diabetic you have no choice but to pay for
insulin no matter the cost of insulin. Insulin prices have increased drastically throughout the
years. It has been found that inulin prices have nearly doubled from 2012-2016 (nbcnews.com).
This is only in the span of 4 years, so will insulin continue to increase in price? This is making it
very hard for diabetic patients to afford insulin. Some patients often resort to using less than the
prescribed amount to make insulin last longer (Hai Global). Serious complications can occur if
patients that are insulin dependent, go without insulin for a long period of time. Diabetes can also
be treated with a good lifestyle and exercise. On average, a gym membership ranges from $30-50
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a month, making it around $800 dollars a year (cnbc). The cost of treatments for diabetes is very
high, not only insulin but a healthy lifestyle also is involved with the treatment of diabetes.
Finding new and improved ways that will lower cost of diabetic treatments need to be developed
so diabetic patients are not left between choosing to pay for insulin or other things they might
need.

Islet of Langerhans -cell research
Although current, effective treatments exist today researchers are looking for ways to
make managing diabetes less expensive and easier. Trying to understand how insulin is made in
the body is important for understanding how to cure it. Islets of Langerhans are found in the
pancreas, which consists of clusters of cells that function in many ways. These are important for
glucose homeostasis. There are about 3.2 to 14.8 million islets in the pancreas. (Da Silva Xavier,
2018). Although there are many types of islets of Langerhans, -cells are the most important to
diabetes because they work to produce the hormone, insulin. There is a potential to be able to use
these cells for diabetic treatments. Transplantation of islet cells is a highly researched topic at the
moment. Taking healthy, islets from a donor, specifically - cells, can help the pancreas produce
insulin on its own.

Treatments being researched
Transforming growth factor (TGFB) has been found (Jing, 2018) to play an important
role in influencing pancreatic endocrine development and maturation. A study done by (Lei,
2014) in china, studied the role in TGFB signaling in -cell proliferation and -cell mass
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adaption after they had performed a 50% partial pancreatectomy. This group of researchers used
mutated mice as their chosen laboratory animal. The mice had their pancreas removed and
studied the results over some period of time. 10 mice were analyzed in each condition. Howeverdid not state the sex of the mice, so would this affect the results or would it be the same? The
researchers performed islet isolation from the biliary pancreatic bile duct. The researchers then
extracted genomic DNA from the isolated islets, they then stained the insulin to identify -cells.
The results from this experiment were found to be similar to other studies done, when you inhibit
TGFB signaling in -cells this resulted in higher -cell production 1 week after they did the
pancreatectomy. However, they also found that -cell mass in the mutated mice decreased 12
weeks after they performed the pancreatectomy which then resulted in the increase of  cell
death. Main conclusion found by the authors (Lei, 2014) was that TGFB signaling may be
required for the prevention of -cell death after proliferation.
Islet Transplantation
Islet Transplantation is used with patients that have type 1 diabetes. Usually islet
transplantation is done with patients that have severe hypoglycemia, and other treatments have
failed. This is done when islet cells are separated from a donor pancreas and then transplanted
into the patients. Islet transplantation is a simple procedure, that is done with patients being
awake and typically takes an hour to be completed. The best part about this procedure is that it is
non-surgical. A catheter is inserted into a portal vein, and into the liver. The islet cells then get
transported into the patient and flow to the liver where they begin to produce insulin. (Bruni,
2014) This procedure sounds very effective, but it does have flaws just like other treatments,
patients that undergo islet transplantation are required to be on immunosuppressive drugs.
Immunosuppressive drugs do just that- they suppress the immune system, which leaves these
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patients at risk for more infections and sicknesses. Studies have shown that islet transplantations
have actually lowered HbA1C in diabetic patients better than insulin pumps and daily multiple
insulin injections. (Bruni, 2014) Islet transplantations have also been found to lower risks of
complications associated with diabetes. Studies have also found that patients that have
undergone islet transplantation during 2007-2010 have a higher success rate than patients that
underwent islet transplantation in 1999-2002. 44% of patients that had the procedure done in
2007-2010 were insulin independent 3 years post procedure. While, only 27% of patients that
had the procedure done in 1999-2002 were insulin independent. (Bruni, 2014) So, the number of
patients that are insulin independent following this procedure doubled in about 8 years. This
suggests that with time and more research, islet transplantation has improved. Although many
transplantation centers around the world are using this treatment, the United States practices few
islet transplantations. Since this is an experimental treatment and the United States has more
regulations, this leads to lack of funds for future research. This is only preformed under a FDA
clinical trial. Not all type 1 diabetic patients are good candidates for islet transplantations. The
outcomes do have to outweigh the risks in order to be considered for islet transplantation. There
are some risks with having this procedure, just like most procedures performed. There is
possibility of blood clots and bleeding out with islet transplantation. Rejection of the islets from
the donor is also possible. The body can react to these foreign cells as if they are “bad” and can
attack the islets. (USCF) This is why patients that do undergo an islet transplantation are required
to be on immunosuppressive drugs to try to keep the body from attacking the healthy islets.

Another problem with islet transplantation is donor availability. Most patients need several
transplantations done to get enough healthy islet cells in their system. (USCF) Islet cells are
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taken from a deceased organ donor. Organ donation is a major topic, since organ donation is not
commonly practiced, pancreas donors are hard to find. Only about 7,000 pancreases are donated
each year, and some are not even healthy enough to be used for “whole organ pancreatic
transplantations.” Since these organs are hard to find and sometimes hard to harvest, this leaves
patients with diabetes type 1 very lost. Factors can also contribute to the success of islet
transplantation. These include, the age of the donor, cause of death and body mass index. A
system, created by O’Gorman has been developed to asses if a pancreas should be used for islet
transplantation, but cannot predict the outcomes. (Bruni, 2014). Islet transplantations would be
one of the best treatments for diabetes type 1, if it didn’t have so many flaws. Studies have
shown that islet transplantations are sometimes more effective than insulin pumps and other
treatments, but there are too many risks and flaws associated with it. Having enough pancreatic
donors is a huge issue, since some patients require multiple islet transplantations there is simply
not enough donors for these transplantations. Also, the risks of the body rejecting the healthy
donor islets is high, and having to be on immunosuppressive drugs increase your potential of
having infections and other disease. If more research is done on islet transplantation and more
clinical trials are preformed, this could be a life changing treatment for type 1 diabetics.

Conclusion
Current treatments for diabetes, although effective have flaws. Treatments can be very expensive
for diabetic patients. Insulin, insulin pumps and proper diets can be a burden for some patients as
well, especially without insurance. Insulin availability is also a problem. Patients in 3rd world
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countries sometimes don’t have the resources available to supply themselves with insulin.
Average cost of insulin in the united states alone is 14 billion dollars. Patients with diabetes type
1 depend on insulin to live, so patients would have to go to extraordinary measures to be able to
stay alive. Researchers have studied Islets of Langerhans to try to understand how -cells are
produced in the pancreas, since these cells are important for maintaining a balanced glucose level
because they create insulin. Islet transplantation does have many flaws that can sometimes
outweigh the positive results Although not a fully accepted and practiced treatment, islet cell
transplantation has been found to be affective in patients. However, from evidence found from
many studies, insulin seems to still be the major diabetic treatment available now. This review
found that although islet transplantation has potential to be one of the best treatments for
diabetes, it is not quite there yet. Availability of donor pancreas’s is low, and the risk of the body
attacking the donor islets is high. This review found that although insulin is expensive and a
burden for diabetic patients, it is still the most effective treatment for diabetes. There still has to
be further research conducted in order to be able to find better treatments. Researchers are going
in the right direction, but given the evidence of what has been presented, it is believed that there
are no other major treatments for diabetes other than insulin.
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